PharmaEssentia Corporation announced changes to remuneration committee. Name and resume of the previous position holder: (1)Independent Director: Patrick Y. Yang, Vice Chairman, National Resilience Inc.(2)Independent Director: JinnDer Chang, Director, CROWN& CO., CPAs, Arbitrator and Consultant, Chinese Arbitration Association, Taipei, (3)Independent Director: JienHeh Tien, Senior Deputy General Manager, XW Pharma, Consultant, SCI Pharmtech. Inc(4)MingChuan Hsieh Director, ScinoPharm Taiwan Ltd. Name and resume of new position holder:(1)Independent Director: JienHeh Tien, Senior Deputy General Manager, XW Pharma, Consultant, SCI Pharmtech.

Inc, (2)Independent Director: ChingTsun Liu, Director, Capital Securities Corporation, Director, Capital Futures Corp., Director, Taiwan Oasis Technology Co. Ltd., (3)Independent Director: MingChuan Hsieh, Director, ScinoPharm Taiwan Ltd. and(4)Independent Director: Jeffrey R. Williams, Director, UBS SDIC Fund Management Company Limited, Director, UBS Asset Management (China) Limited and Board Member, UBS Optimus Foundation. Reason for the change is term expired/new appointment.

Original term is from August 16, 2021 to August 15, 2024. Effective date of the new member is June 28, 2024.